Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility

Carcinogenesis

Volumn 26, Issue 6, 2005, Pages 1117-1121

  Zhou, Yifeng ^a   Yu, Chunyuan ^a   Miao, Xiaoping ^a   Wang, Yonggang ^a   Tan, Wen ^a   Sun, Tong ^a   Zhang, Xuemei ^a   Xiong, Ping ^a,b   Lin, Dongxin ^a  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; MIDDLE AGED; PROMOTER REGION; RISK;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK; SMOKING;

EID: 22344455283     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi057     Document Type: Article

References (40)

1. Chambers, A.F. and Matrissian, L.M. (1997) Changing views of the role of matrix metalloproteinase in metastasis. J. Natl Cancer Inst., 89, 1260-1270.
2. Curran, S. and Murray, G.I. (1999) Matrix metalloproteinases in tumour invasion and metastasis. J. Pathol., 189, 300-308.
3. Stamenkovic, I. (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol., 10, 415-433.
4. Xie, T.X., Wei, D., Liu, M., Gao, A.C., Ali-Osman, F., Sawaya, R. and Huang, S. (2004) Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene, 23, 3550-3560.
5. Ross, J.S., Kaur, P., Sheehan, C.E., Fisher, H.A., Kaufman, R.A. Jr and Kallakury, B.V. (2003) Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer. Mod. Pathol., 16, 198-205.
6. Bodey, B., Bodey, B. Jr., Groger, A.M., Siegel, S.E. and Kaiser, H.E. (2001) Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung. In Vivo, 15, 175-180.
7. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
8. McCaswley, L.J. and Matrisian, L.M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol., 13, 534-540.
9. Sternlicht, M.D. and Werb, Z. (1999) Matrix metalloproteinase. In Kreis, T. and Vale, R. (eds) Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins. Oxford University Press, New York, 1999, pp. 503-603.
10. Galateau-Salle, F.B., Luna, R.E., Horiba, K., et al. (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. Hum. Pathol., 31, 296-305.
11. Schmalfeldt, B., Prechtel, D., Harting, K., et al. (2001) Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res., 7, 2396-2404.
12. Bergers, G., Brekken, R., Mcmahon, G., et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol., 2, 737-744.
13. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res., 58, 1048-1051.
14. Price, S.J., Greaves, D.R. and Watkins, H. (2000) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J. Biol. Chem., 276, 7549-7558.
15. Harendza, S., Lovett, D.H., Panzer, U., Lukacs, Z., Kuhnl, P. and Stahl, R.A. (2003) Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J. Biol. Chem., 278, 20490-20499.
16. Yu, C., Zhou, Y., Miao, X., Xiong, P., Tan, W. and Lin, D. (2004) Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res., 64, 7622-7628.
17. Yu, C., Pan, K., Xing, D., Liang, G., Tan, W., Zhang, L. and Lin, D. (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res., 62, 6430-6433.
18. Miao, X., Yu, C., Tan, W., Xiong, P., Liang, G., Lu, W. and Lin, D. (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res., 63, 3987-3990.
19. Zhou, Y., Yu, C., Miao, X., Tan, W., Liang, G., Xiong, P., Sun. T. and Lin, D. (2003) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis, 25, 399-404.
20. Lin, S.C., Lo, S.S., Liu, C.J., Chung, M.Y., Huang, J.W. and Chang, K.W. (2004) Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J. Oral Pathol. Med., 33, 405-409.
21. Xu, E., Lai, M., Lv, B., Xing, X., Huang, Q. and Xia, X. (2004) A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem. Biophys. Res. Commun., 324, 999-1003.
22. Ott, J. (2002) Predicting the range of linkage disequilibrium. Proc. Natl Acad. Sci. USA, 97, 2-3.
23. Stephens, M, Smith, N.J. and Donnelly, P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
24. Kleinbaum, D.G., Kupper, L.L. and Morgenstern, H. (1982) Epidemiologic Research: Principles and Quantitative Methods. Lifetime Learning Publications, London, UK.
25. Brennan, P. (2002) Gene-environment interaction and etiology of cancer: what does it mean and how we measure it? Carcinogenesis, 23, 381-387.
26. Brummer, O., Athar, S., Riethdorf, L., Loning, T. and Herbst, H. (1999) Matrix metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch., 435, 566-573.
27. Caudroy, S., Polette, M., Tournier, J.M., Burlet, H., Toole, B., Zucker, S. and Birembaut, P. (1999) Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions. J. Histochem. Cytochem., 47, 1575-1580.
28. Thomas, P., Khokha, R., Shepherd, F.A., Feld, R. and Tsao, M.S. (2000) Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J. Pathol., 190, 150-156.
29. Soini, Y., Paakko, P. and Autio-Harmainen, H. (1993) Genes of laminin B1 chain, α1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. Am. J. Pathol., 142, 1622-1630.
30. Nawrocki, B., Polette, M., Marchand, V., Monteau, M., Gillery, P., Tournier, J.M. and Birembaut, P. (1997) Expression of matrix metallo-proteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int. J. Cancer, 72, 556-564.
31. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res., 58, 1048-1051.
32. Ha, H.Y., Moon, H.B., Nam, M.S., et al. (2001) Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res., 61, 984-990.
33. Zhu, Y., Spitz, M.R., Lei, L., Mills, G.B. and Wu, X. (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res., 61, 7825-7829.
34. Hinoda, Y., Okayama, N., Takano, N., Fujimura, K., Suehiro, Y., Hamanaka, Y., Hazama, S., Kitumura, Y., Kamatani, N. and Oka, M. (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 gene with colorectal cancer. Int. J. Cancer, 102, 526-529.
35. Nishioka, Y., Kobayashi, K., Sagae, S., et al. (2000) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn. J. Cancer Res., 91, 612-615.
36. Kanamori, Y., Matsushima, M., Minaguchi, T., Kobayashi, K. Sagae, S., Kudo, R., Terakawa, N. and Nakamura, Y. (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancer and insertion/deletion polymorphism in its promoter region. Cancer Res., 59, 4225-4227.
37. Ghilardi, G., Biondi, M.L., Caputo, M., Leviti, S., DeMonti, M., Guagnellini, E. and Scorza, R. (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res., 8, 3820-3823.
38. Zhang, J., Jin, X., Fang, S., et al. (2004) The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis, 25, 2519-2524.
39. Lahmann, C., Bergemann, J., Harrison, G. and Young, A.R. (2001) Matrix metalloproteinase-1 and skin ageing in smokers. Lancet, 357, 935-936.
40. Russell, R.E., Culpitt, S.V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J. and Barnes, P.J. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol., 26, 602-609.